Biochemical and behavioral changes in rats after prolonged treatment with desipramine: interaction with p-chlorophenylalanine

Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):20-2. doi: 10.1007/BF00498847.

Abstract

The decrease in the Bmax value of 3H-dihydroalprenolol (3H-DHA) binding to cortical membranes of rat brain induced by long-term administration of desipramine (DMI) was prevented by concomitant treatment with parachlorophenylalanine (pCPA). Acute administration of DMI significantly decreased locomotor activity in saline- and (pCPA)-pretreated rats. DMI-induced inhibition of locomotor activity was abolished in (pCPA)-pretreated rats chronically treated with DMI. Conversely, in pCPA-pretreated animals, acute DMI could still significantly decrease the locomotion of chronically DMI-treated rats. The data presented indicate that an intact serotoninergic system is required to enable antidepressant drugs to induce biochemical and behavioral changes following their chronic administration.

MeSH terms

  • Animals
  • Brain Chemistry / drug effects*
  • Desipramine / pharmacology*
  • Drug Interactions
  • Fenclonine / pharmacology*
  • Kinetics
  • Male
  • Motor Activity / drug effects*
  • Rats
  • Rats, Inbred Strains
  • Serotonin / biosynthesis

Substances

  • Serotonin
  • Fenclonine
  • Desipramine